Business Description
ICL Group Ltd, a global enterprise specializing in the production of minerals and chemicals, conducts its operations through four distinct business units. The company, which originated as Israel Chemicals Ltd and adopted its current name in May 2020, was founded in 1968 and maintains its headquarters in Tel Aviv, Israel. The Industrial Products segment is responsible for extracting bromine from a byproduct solution generated during potash production, subsequently manufacturing bromine-based compounds. It also produces various grades of potash, salt, magnesium chloride, and magnesia products, alongside the creation and distribution of phosphorus-based flame retardants and other phosphorus derivatives. Within its Potash division, ICL sources potash from the Dead Sea, while simultaneously engaging in the mining and production of potash and salt. This segment is also a producer of Polysulphate, and it manufactures and markets magnesium and its alloys, along with associated by-products like chlorine and sylvinite. Additionally, it sells salt. The Phosphate Solutions segment converts foundational phosphate commodities into specialized products. It manufactures and distributes phosphate-based fertilizers, sulphuric acid, and green phosphoric acid. This unit also produces thermal phosphoric acid for a diverse array of industrial uses, spanning sectors such as oral hygiene, cleaning products, paints and coatings, water treatment, asphalt modification, construction, and metal treatment. Moreover, it develops and produces functional food ingredients and phosphate additives for application in the processed meat, poultry, seafood, dairy, beverage, and baked goods markets, as well as manufacturing milk and whey proteins for the broader food ingredients industry. Finally, the Innovative Ag Solutions (IAS) segment focuses on the development, manufacturing, marketing, and sale of fertilizers primarily composed of nitrogen, potash, and phosphate. This includes a spectrum of products such as water-soluble specialty, liquid, soluble, and controlled-release fertilizers. ICL Group's diverse product portfolio reaches global markets through an established network of marketing firms, agents, and distributors.
Business History
Price Overview
Last updated: Jun 27, 2026 9:00am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 0.18
Total Equity: $5.98B
Shares: 1,291,395,000
Total Debt: $2.58B
Cash: $291.00M
EBITDA: $1.35B
Total Debt: $2.58B
Cash: $291.00M
Revenue: $7.15B
Revenue: $7.15B
Revenue: $7.15B
Total Equity: $5.98B
Tax Rate: 36.5%
Equity: $5.98B
Total Debt: $2.58B
Cash: $291.00M
Current Liabilities: $3.13B
Long-Term Debt: $1.70B
Total Debt: $2.58B
Total Equity: $5.98B
Shares: 1,291,395,000
Shares: 1,291,395,000
CapEx: -$824.00M
Shares: 1,291,395,000
Stock Price: $5.02
Net Income: $226.00M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 21, 2026 6:56pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $7.0B | $10.0B | $7.5B | $6.8B | $7.2B |
| Cost of Revenue | $4.3B | $5.0B | $4.9B | $4.6B | $5.0B |
| Gross Profit | $2.6B | $5.0B | $2.7B | $2.3B | $2.2B |
| Operating Expenses | $1.4B | $1.5B | $1.5B | $1.5B | $1.5B |
| Operating Income | $1.2B | $3.5B | $1.1B | $775.0M | $703.0M |
| Net Income | $783.0M | $2.2B | $647.0M | $407.0M | $226.0M |
| EBITDA | $1.7B | $4.0B | $1.7B | $1.4B | $1.4B |
| EPS | $0.63 | $1.60 | $0.50 | $0.32 | $0.18 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 21, 2026 6:56pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $473.0M | $417.0M | $420.0M | $327.0M | $291.0M |
| Total Current Assets | $3.9B | $4.5B | $4.0B | $3.6B | $4.2B |
| Total Assets | $11.1B | $11.8B | $11.6B | $11.3B | $12.4B |
| Current Liabilities | $2.6B | $2.6B | $2.6B | $2.3B | $3.1B |
| Long-Term Debt | $2.2B | $2.1B | $1.6B | $1.7B | $1.7B |
| Total Liabilities | $6.3B | $6.0B | $5.6B | $5.3B | $6.2B |
| Total Equity | $4.5B | $5.5B | $5.8B | $5.7B | $6.0B |
| Retained Earnings | $4.3B | $5.4B | $5.6B | $5.8B | $5.8B |
Cash Flow (Annual)
Last updated: Jun 21, 2026 6:56pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $2.1B | $1.6B | $1.4B | $954.0M |
| Capital Expenditure | -$611.0M | -$747.0M | -$780.0M | -$713.0M | -$824.0M |
| Free Cash Flow | $454.0M | $1.4B | $815.0M | $650.0M | $130.0M |
| Acquisitions (net) | -$365.0M | -$18.0M | $4.0M | -$55.0M | -$11.0M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $259.0M | -$56.0M | $3.0M | -$93.0M | -$36.0M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 9:00am (just now)| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$7.2B $7.1B – $7.2B
|
$7.9B $7.8B – $7.9B
|
$8.0B $7.9B – $8.0B
|
$8.2B $8.2B – $8.3B
|
| EBITDA |
$1.8B $1.8B – $1.8B
|
$2.0B $2.0B – $2.0B
|
$2.0B $2.0B – $2.0B
|
$2.1B $2.1B – $2.1B
|
| Net Income |
$463.5M $459.7M – $467.3M
|
$540.7M $536.3M – $545.1M
|
$581.0M $576.3M – $585.8M
|
$610.2M $605.1M – $615.1M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 21, 2026 6:56pm (5d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +44.0% | -24.8% | -9.2% | +4.6% |
| Gross Profit Growth | +92.7% | -46.9% | -15.5% | -3.1% |
| Operating Income Growth | +190.6% | -67.5% | -32.1% | -9.3% |
| Net Income Growth | +175.7% | -70.0% | -37.1% | -44.5% |
| EBITDA Growth | +134.4% | -58.7% | -17.5% | -1.7% |
Insider Trading (Recent)
All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-14 | Alperovitz Asaf | 0.00 | $0.00 | $0 | |
| 2026-05-24 | Kilstein Alegra | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Perelman Uri | 1,139,990.00 | $6.03 | $6.9M | |
| 2026-03-18 | Perelman Uri | 739,400.00 | $6.93 | $5.1M | |
| 2026-03-18 | Doppelt Yoav | 1,055,100.00 | $11.05 | $11.7M | |
| 2026-03-18 | Doppelt Yoav | 1,973,684.00 | $6.73 | $13.3M | |
| 2026-03-18 | Kabalek Yaniv | 348,928.00 | $8.33 | $2.9M | |
| 2026-03-18 | Kabalek Yaniv | 627,793.00 | $5.87 | $3.7M | |
| 2026-03-18 | Ilani Nir | 560,538.00 | $7.33 | $4.1M | |
| 2026-03-18 | Mishor MIRIAM | 464,902.00 | $9.39 | $4.4M | |
| 2026-03-18 | Mishor MIRIAM | 620,177.00 | $5.87 | $3.6M | |
| 2026-03-18 | Grinfeld Maya | 189,846.00 | $7.33 | $1.4M | |
| 2026-03-18 | Geva Harel Lilach | 649,180.00 | $9.39 | $6.1M | |
| 2026-03-18 | Geva Harel Lilach | 984,095.00 | $5.87 | $5.8M | |
| 2026-03-18 | Geva Harel Lilach | 416,667.00 | $5.91 | $2.5M | |
| 2026-03-18 | Fahima Ilana | 649,180.00 | $9.39 | $6.1M | |
| 2026-03-18 | Fahima Ilana | 984,095.00 | $5.87 | $5.8M | |
| 2026-03-18 | Aharonson Elad | 306,748.00 | $6.39 | $2.0M | |
| 2026-03-18 | Aharonson Elad | 737,705.00 | $9.39 | $6.9M | |
| 2026-03-18 | Aharonson Elad | 1,118,290.00 | $5.87 | $6.6M |
Dividend History (Last 20)
Last updated: Jun 21, 2026 6:56pm (5d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-06-02 | $0.05 | 2026-05-13 | 2026-06-02 | 2026-06-17 |
| 2026-03-10 | $0.05 | 2026-03-10 | 2026-03-25 | |
| 2025-12-02 | $0.05 | 2025-12-02 | 2025-12-17 | |
| 2025-09-03 | $0.04 | 2025-09-03 | 2025-09-17 | |
| 2025-06-04 | $0.04 | 2025-06-04 | 2025-06-18 | |
| 2025-03-12 | $0.04 | 2025-02-26 | 2025-03-12 | 2025-03-25 |
| 2024-12-04 | $0.05 | 2024-11-11 | 2024-12-04 | 2024-12-18 |
| 2024-09-04 | $0.05 | 2024-08-14 | 2024-09-04 | 2024-09-18 |
| 2024-06-06 | $0.05 | 2024-06-06 | 2024-06-20 | |
| 2024-03-13 | $0.05 | 2024-02-28 | 2024-03-14 | 2024-03-26 |
| 2023-12-04 | $0.05 | 2023-11-08 | 2023-12-05 | 2023-12-20 |
| 2023-08-29 | $0.06 | 2023-08-09 | 2023-08-30 | 2023-09-13 |
| 2023-05-30 | $0.11 | 2023-05-11 | 2023-05-31 | 2023-06-14 |
| 2023-02-28 | $0.14 | 2023-02-16 | 2023-03-01 | 2023-03-15 |
| 2022-11-29 | $0.18 | 2022-11-10 | 2022-11-30 | 2022-12-14 |
| 2022-08-30 | $0.23 | 2022-07-28 | 2022-08-31 | 2022-09-14 |
| 2022-05-31 | $0.24 | 2022-05-27 | 2022-06-01 | 2022-06-15 |
| 2022-02-22 | $0.10 | 2022-02-10 | 2022-02-23 | 2022-03-08 |
| 2021-12-01 | $0.08 | 2021-11-05 | 2021-12-02 | 2021-12-15 |
| 2021-08-17 | $0.11 | 2021-07-28 | 2021-08-18 | 2021-09-01 |
Narrative Economics
market-narrative step).